Biotech Research Group
Private Company
Funding information not available
Overview
Biotech Research Group is a privately held, revenue-generating consulting firm founded in 2010, operating in the services sector of the biotech industry. It provides end-to-end regulatory, product development, and quality assurance consulting for a broad range of products including biologics, drugs, and medical devices. BRG leverages a global network of experts to offer cost- and time-effective solutions aimed at accelerating client products through development and regulatory approval, with a noted specialty in Emergency Use Authorizations such as for COVID-19.
Technology Platform
Integrated global network of regulatory and scientific experts providing a one-stop-shop service framework for product development and compliance, specializing in FDA and international regulations.
Pipeline
1| Drug | Indication | Stage | Watch |
|---|---|---|---|
| Pelareorep + Letrozole + Atezolizumab + Trastuzumab | Breast Cancer | Phase 1 |
Opportunities
Risk Factors
Competitive Landscape
BRG competes in the crowded regulatory consulting and CRO space, facing competition from large global CROs (e.g., IQVIA, Parexel) that offer similar services at scale, as well as numerous small, specialized consulting boutiques. Its differentiation is based on its positioning as a full-service, cost-effective firm with a global expert network and a strong emphasis on expedited timelines.